Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02652000
Other study ID # KEK-ZH-Nr. 2015-0573
Secondary ID
Status Completed
Phase N/A
First received January 6, 2016
Last updated December 11, 2016
Start date October 2009
Est. completion date December 2016

Study information

Verified date December 2016
Source Kantonsspital Graubuenden
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Observational

Clinical Trial Summary

Retrospective study to analyze Quality of life in men after iodine seed brachytherapy for localized prostate cancer


Description:

Retrospective Evaluation of Quality of life data collected on men who underwent iodine seed brachytherapy at the University Hospital Zurich


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Male
Age group 48 Years to 80 Years
Eligibility Inclusion Criteria:

- Male > 18 years of age

- iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Exclusion Criteria:

- No iodine seed brachytherapy for localized prostate cancer at the University Hospital Zurich

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Other:
No intervention in this retrospective study
No Intervention in this retrospective Analysis.

Locations

Country Name City State
Switzerland Kantonsspital Graubuenden, Department of Radiaton Oncology Chur

Sponsors (2)

Lead Sponsor Collaborator
Kantonsspital Graubuenden University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary CTCAE v4.03ff Grade 1-4 Sexual/Reproductive Function Scale 5 years (2009-2014) No
Secondary CTCAE v4.03ff Grade 1-4 Gastrointestinal Scale 5 years (2009-2014) No
Secondary CTCAE v4.03ff Grade 1-4 Renal/Genitourinary Scale 5 years (2009-2014) No
Secondary International Prostate Symptom Score (IPSS) Scale 5 years (2009-2014) No
Secondary International Index of erectile function, five items (IIEF-5) Scale 5 years (2009-2014) No
See also
  Status Clinical Trial Phase
Completed NCT00970203 - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer Phase 2
Completed NCT00558363 - ARTS - AVODART After Radical Therapy For Prostate Cancer Study Phase 2
Completed NCT02153918 - Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy Phase 2
Completed NCT01371513 - Korean Practice Patterns for Screening PCA(Prostate Cancer) N/A
Completed NCT00470834 - Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy Phase 4
Completed NCT00056407 - "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Phase 3
Completed NCT00148928 - Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSA Phase 1
Completed NCT01477749 - Sipuleucel-T Manufacturing Demonstration Study Phase 2
Completed NCT00363311 - Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men Phase 4
Completed NCT01337258 - Economic Analyses of the REDUCE Trial N/A
Terminated NCT02349139 - Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer Phase 1
Active, not recruiting NCT04249947 - P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) Phase 1
Completed NCT00883909 - ARI103094-Follow-Up Study for REDUCE Study Subjects N/A